144 results
8-K
EX-99.1
JAZZ
Jazz Pharmaceuticals plc
21 Dec 22
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab
7:40am
, Barriuso J, Zhu AX. New Horizons for precision medicine in biliary tract cancers. Cancer Discov. 2017;7(9):943-962.
2GBD 2017 Disease and Injury
8-K
EX-2.1
JAZZ
Jazz Pharmaceuticals plc
5 Dec 22
Completion of Acquisition or Disposition of Assets
4:16pm
(9):943-962.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years
8-K
EX-99.1
cxv08
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:59am
8-K
EX-99.1
evf yaejuhoa6igc
23 Apr 21
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
4:26pm
8-K
EX-10.1
9qlog 4n6
20 Apr 21
Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes
9:01am
DFAN14A
xdtlg68yq0qm4ijt wq
26 Feb 21
Additional proxy materials by non-management
12:00am
DFAN14A
zfrxt8q2em11fys
4 Feb 21
Additional proxy materials by non-management
2:21pm